Skip to main content
. 2018 May 2;13:83. doi: 10.1186/s13014-018-1035-9

Table 5.

Univariate and multivariate analysis for Progression Free Survival

Univariate Analysis Multivariate Analysis
Variable HR (95% CI) p-value HR (95%CI) p-value
Age > 65 1.04 (0.39–1.70) 0.82 NA NA
Male sex 1.17 (0.44–1.90) 0.52 NA NA
G3 vs G1
G2 vs G1
1.87 (0.90–3.88)
1.76 (0.51–6.10)
0.92
0.38
NA
NA
NA
NA
T3-T4 vs T1-T2 1.73 (0.89–3.33) 0.11 NA NA
N + ve vs N -ve 2.16 (1.18–3.96) 0.012 1.98 (1.01–3.88) 0.046
RT total dose 1.12 (0.79–1.58) 0.52 NA NA
Boost: yes vs no 0.84 (0.32–2.18) 0.72 NA NA
OTT > 42 days 1.18 (0.53–1.85) 0.38 NA NA
Hb 0.57 (0.39–0.85) 0.005 0.78 (0.53–1.15) 0.12
Response 5.39 (2.79–10.4) < 0.0001 5.43 (2.75–10.70) < 0.0001

RT Radiotherapy, Hb Basal haemoglobin levels (gr/dl), Boost Radiotherapy boost: given vs not, Response Incomplete response vs complete response, OTT Total legth of chemo-radiation treatment, N node, +ve positive, −ve negative, HR hazard ratio, CI confidence interval, NA not available